Asia Fresh News

Asia Fresh Stories

Archive for May 15th, 2015

Travel To Sydney This Winter For The World’s Largest Creative Festival -VIVID SYDNEY-

leave a comment »

SYDNEY /PRNewswire/ — See Sydney come alive in the most spectacular way during Vivid Sydney 2015 when the world’s largest festival of light, music and ideas is staged in this spectacular harbour city. For 18 nights, from 22 May  8 June, Vivid Sydney will again transform the city and harbour into a mesmerising free public exhibition of outdoor lighting sculptures and installations.

Vivid Light is an incredible light show that blankets Sydney’s most iconic landmarks in a vibrant display of colour and movement. From 6pm to midnight each night, enchanting light installations and grand-scale 3D projections illuminate the sails of the Sydney Opera House along with more than 60 ‘light art’ sculptures located all through the city to turn night-time into play-time.

The 2015 program includes expansion into new city precincts Chatswood and Central Park as well as expanded offerings at Pyrmont and The Star and The University of Sydney which will see Vivid Sydney’s light shine further into the city and the suburbs. Of course there’s Vivid Music and the Vivid Ideas seminar program with amazing speakers to entertain, provoke and delight!

Australia Travel Centre has embraced the Vivid Sydney festival with a special Vivid Stay and Play package fromUS $1,455 per person.

What’s included:

  • 3 nights’ accommodation
  • Return economy airfare to Sydney on Garuda
  • Captain Cook Harbour Lunch Cruise, Vivid Light Cruise, city tour of iconic Sydney landmarks, full day Blue Mountains Tour with Scenic rides, fullboard meals

Travel dates: Valid for travel to be completed by 08 Jun 15

What not to miss:

Sydney Opera House  Lighting the Sails

One of the most recognisable installations part of Vivid Sydney. The Lighting of the Sails sees mesmerising digital artwork projected onto the sails of the Sydney Opera House each night. Playing with technology to invent new forms of design and moving imagery, Universal Everything (UK) has created a digital artwork bound to amaze.

Customs House  Enchanted Sydney

From Vivid Sydney regulars, Spinifex, comes Enchanted Sydney, a glorious projection of free-flowing images of Sydney’s flora and fauna on the iconic facade of Customs House. The artwork mixes familiar (and not so familiar) aspects of Sydney’s natural environment to create a continually evolving and blossoming world.

Museum of Contemporary Art Australia  Mechanised Colour Assemblage

A Vivid Sydney favourite, the Museum of Contemporary Art Australia (MCA) will be back in 2015 with an entrancing twist. Mechanised Colour Assemblage which will transform the MCA facade into a series of sound and colour ‘machines’ that create a continuously morphine, audiovisual experience that blends voices and colours together into a single element.

Paint The Town

Paint the Town is a cutting edge, interactive illumination from 32 Hundred and Iain Reed that will transform the world famous view of Sydney Harbour into a breathtaking canvas of light.

In 2015, Vivid Sydney will be bigger than ever, expanding into five precincts and offering more than 60 light displays and projections, as well as an impressive line-up of more than 70 music performances and 150 Ideas talks.

The biggest-ever Vivid Music program will feature Australian-exclusives such as The Hoodoo Gurus at the Powerhouse Museum and Daniel Johns’ international solo debut at the Sydney Opera House.

Vivid Ideas will introduce The Game Changers, a new talks series headlined by three global influencers which include multi Emmy-winning writer Matthew Weiner, series creator and executive producer of Mad Men and former executive producer and writer on The Sopranos; Grammy-winning designer Stefan Sagmeister, whose clients include the Rolling Stones, Lou Reed and the Guggenheim Museum; and entrepreneur and publisher Tyler Brule, founder of the world-famous magazines Wallpaper and Monocle.

For further details, terms and conditions and to book please visit:

For further details on Vivid Sydney please visit

The full Vivid Sydney media kit and high-res imagery including 2015 Vivid Sydney light renders and footage of 2014 festival highlights is available at

Source: Destination NSW

Written by asiafreshnews

May 15, 2015 at 4:33 pm

Posted in Uncategorized

Pepsi®, Usher And UrtheCast Partner To Create An Epic Film Adventure

leave a comment »

PURCHASE, New York, May 12, 2015 /PRNewswire/ — #PEPSICHALLENGE – In a first-of-its-kind, Pepsi® is creating and producing a short film that will include footage from UrtheCast – the world’s first full-color Ultra High-Definition video system located aboard the International Space Station (ISS), feature Pepsi consumers from around the world and leverage the creative and artistic direction of eight-time Grammy award winning entertainerUsher. As part of this year’s Pepsi® Challenge™ campaign, the interstellar short film combines video, music, technology and storytelling, with Pepsi consumers across the globe playing a role in the experience.

Video –
Video –
Photo –

“On one level, the ambition of this short film is mind-boggling because it’s an original screenplay that features real-life footage shot from outer-space,” said Frank Cooper III, Chief Marketing Officer, Global Consumer Engagement, PepsiCo Global Beverages Group. “But, having visionary creators, cutting-edge technologists like UrtheCast and an iconic artist like Usher make it a realistic, exciting collaboration across tech, film, music and pop culture.”

To be released this fall, the short film will be shot from multiple locations and perspectives – both on Earth and in space. Designed to unite and inspire generations around the world as part of the #PepsiChallenge, Pepsi will invite consumers to participate in this unique film phenomenon. Filming will take place in more than 10 countries across four continents where thousands of consumers will join together to be filmed by UrtheCast’s proprietary HD video camera – permanently and impressively leaving their mark on history as part of this once-in-a-lifetime experience.

While UrtheCast captures a powerful perspective from space that few have ever experienced, Usher will invite fans to capture through a single photo an image that they feel inspires and amazes others to look at the world in a new way. Beginning today through June 2nd, fans around the world can submit one photo each day Usher will select the most powerful image and invite the talent behind the lens to meet him on set at the upcoming film shoot, with the winning image also featured in the short film. For contest official rules, including eligibility requirements, and to view a selection of the best images from around the world,

“Throughout my career, I’ve had the opportunity to be a part of some truly amazing experiences,” said Usher. “I’ve always tried to push boundaries and to inspire others to go beyond what they perceive as their limits. I feel fortunate to have the opportunity to partner with Pepsi and UrtheCast to be a part of creating this intergalactic short film shot from space and am excited to jump in and take on this once-in-a-lifetime challenge and experience.”

With a launch that marked #PepsiChallenge as the #1 Twitter trending topic worldwide, and engagements by and with Pepsi global brand ambassadors and international luminaries, fashion houses and sports celebrities alike, the Pepsi Challenge continues throughout 2015 with additional global and local challenges designed to galvanize consumers around the world to live life to the fullest and make every moment – big or small – epic. Challenges are issued on Pepsi social channels, and via global and local ambassadors. Visit and Pepsi social channels around the world for more information and challenge details.

About PepsiCo

PepsiCo products are enjoyed by consumers one billion times a day in more than 200 countries and territories around the world. PepsiCo generated more than $66 billion in net revenue in 2014, driven by a complementary food and beverage portfolio that includes Frito-Lay, Gatorade, Pepsi-Cola, Quaker and Tropicana. PepsiCo’s product portfolio includes a wide range of enjoyable foods and beverages, including 22 brands that generate more than $1 billion each in estimated annual retail sales. At the heart of PepsiCo is Performance with Purpose – our goal to deliver top-tier financial performance while creating sustainable growth and shareholder value. In practice, Performance with Purpose means providing a wide range of foods and beverages from treats to healthy eats; finding innovative ways to minimize our impact on the environment and reduce our operating costs; providing a safe and inclusive workplace for our employees globally; and respecting, supporting and investing in the local communities where we operate. For more information, visit

About UrtheCast Corp.

UrtheCast Corp. is a Vancouver-based technology company that is developing the world’s first Ultra HD video feed of Earth, streamed from space in full color. Working with renowned aerospace partners from across the globe, UrtheCast has built, launched, installed, and will soon operate two cameras on the ISS. Video and still image data captured by the cameras will be downlinked to ground stations across the planet and displayed on the UrtheCast web platform, or distributed directly to partners and customers. UrtheCast’s cameras will provide Ultra HD video and still imagery of Earth that will allow for monitoring of the environment, humanitarian relief, social events, agricultural land, etc. Common shares of UrtheCast trade on the Toronto Stock Exchange as ticker ‘UR’.

UrtheCast Forward-Looking Information

This release contains certain information about UrtheCast which constitutes “forward-looking information” within the meaning of Canadian securities laws. Forward-looking information involves statements that an action or event “will” occur (or similar language) and includes statements about plans to operate cameras on the ISS, proposed imagery products and expected partners. These statements are subject to various risks, many of which are beyond the ability of UrtheCast to control or predict, and which may cause UrtheCast’s actual results to be materially different, including, but not limited to, the cameras failing to operate as expected, or at all, as well as those factors discussed in the UrtheCast’s short form prospectus dated April 7, 2014 and prospectus supplement dated April 10, 2015 (together, the “Prospectus”) which are available under UrtheCast’s SEDAR profile Forward-looking information is developed based on assumptions about such risks, uncertainties and other factors set out herein, in the Prospectus, and as disclosed from time to time on UrtheCast’s SEDAR profile. UrtheCast undertakes no obligation to update forward-looking statements except as required by Canadian securities laws. Readers are cautioned against attributing undue certainty to forward-looking statements.

Source: PepsiCo

Written by asiafreshnews

May 15, 2015 at 4:13 pm

Posted in Uncategorized

Maxion Wheels Will Attend Automechanika Trade Fair in Dubai

leave a comment »

KONIGSWINTER, Germany, May 12, 2015 /PRNewswire/ — Maxion Wheels will exhibit at the international trade fair Automechanika in Dubai from 2 – 4 June 2015. With a display area of 50 m², Maxion Wheels will present the latest developments in truck wheels with a focus on its Gen35™ product. The Gen35™ truck steel wheel is 6% lighter than the former wheel generation, and 3.5 % lighter than any equally-sized truck wheel available in the worldwide market that has been tested to the LBF ZWARP requirement. Customers will be able to see the diversity and excellent quality of Maxion Wheels’ truck steel wheels and can discuss future projects with their sales contacts. Maxion Wheels’ representatives from Turkey and India will occupy Booth No. 216 in Hall S2. For more information, check .

Logo –

About Maxion Wheels

Maxion Wheels is a leading worldwide producer of aluminum and steel wheels for passenger cars and light trucks and of steel wheels for commercial trucks and trailers. The Company has global operations with 25 facilities, including business, sales offices and manufacturing facilities, located in 15 countries around the world. The Company sells products to every major North American and South American, Asian and European manufacturer of passenger cars and light trucks and to commercial vehicle customers throughout the,

Source: Maxion Wheels

Written by asiafreshnews

May 15, 2015 at 4:05 pm

Posted in Uncategorized

Presima strengthens client focus with new hire

leave a comment »

MONTREAL, May 12, 2015 /PRNewswire/ — Presima today announced the appointment of Francois Forget, CFA, as Executive Vice-President, Global Head of Client Service and Business Development.

Francois joins the team with over 14 years of professional experience as a portfolio manager, equity research analyst, and, most recently, in product development, client service and business development.

“We are very excited to welcome Francois, a seasoned professional who is very well-regarded within the investment community.  Francois comes to us from one of the world’s largest asset management firms and has significant experience across a range of investment management roles including five years as a portfolio manager,” said Peter Zabierek, Presima’s Chief Executive Officer.

“As a small boutique manager, we’ve always focused on delivering the best client service in the world.  We’re excited that Francois’ mixture of investment and client service experience will help us deliver on this promise.”

Prior to joining Presima, Francois was a Vice President, Business Development and Consultant Relationships with Standard Life Investments in Montreal.

Francois holds a Master’s degree in Finance from HEC Montreal and is a CFA Charterholder.

Notes to editors

About Presima
Presima is a Montreal-based investment boutique that specializes in the management of global real estate securities on behalf of institutional and other investors. Presima is part of National Australia Bank’s (NAB) direct asset management business, NAB Asset Management, which partners with the best of breed investment managers, providing the strength of the NAB Group’s resources. Presima has been managing real estate securities portfolios for over 10 years.

For more information: Robin Marcoux, 514-673-1303,,

Source: Presima Inc.
Related Links:

Written by asiafreshnews

May 15, 2015 at 3:59 pm

Posted in Uncategorized

Gold Star Line to Launch a New China-Korea-Philippine Service

leave a comment »

HONG KONG, May 12, 2015 /PRNewswire/ — Gold Star Line is pleased to announce the new China-Korea-Philippine Service (CKP), offering best-in-market transit time and convenient calls suited to customers’ needs.

The new service rotation:
QingdaoPusanShanghaiManila (South) – Manila (North) – Qingdao

Among the exclusive offerings of CKP:

  • Direct weekly ShanghaiManila calls, with a fast 5-day transit time
  • Fastest QingdaoManila transit time
  • Exclusive for the Korean market: calling both north and south Ports of Manila
  • Suitable schedule for growing reefers’ market
  • Ample special equipment pool to offer un-interrupted equipment supply, with protected reefer plugs
  • Preferred terminals at all major ports

Honda Lin, GSL Commercial Director: “The new CKP service joins our network of Intra-Asia services, providing an excellent solution based on market needs. With GSL’s long standing commitment to customer service, it will greatly benefit GSL’s customers.”

William Liu
Gold Star Line Hong Kong

Written by asiafreshnews

May 15, 2015 at 3:56 pm

Posted in Uncategorized

Anisina Confirmed as Effective Anti-Cancer Agent in Animal Studies

leave a comment »

-Anti-tumor effect in mice with human melanoma cells
-Oral dosing effective with no observed toxicity

SYDNEY/PRNewswire/ — US-Australian drug discovery company, Novogen (NRT:ASX; NVGN: NASDAQ), today announced that it has confirmed that drug candidate, Anisina, is an effective monotherapy against human melanoma in an animal model.

The Company announced recently that Anisina was a potent cytotoxic in vitro against human melanoma cells, and in particular that this effect was unaffected by the mutational status of the melanoma cells, particularly the common Braf gene status.

The purpose of the pre-clinical study was to provide evidence that this potent anti-cancer effect could be transferred to the whole animal. Such evidence is required to justify conducting human clinical studies in adults with solid cancers such as melanoma. The Company previously has announced the effectiveness of Anisina as a monotherapy in mice bearing human neuroblastoma tumors, thereby justifying taking it into clinical trials in children and juveniles with solid cancers such as neuroblastoma. Taken together, the two results confirm the potential clinical benefit of this drug across both adult and paediatric cancers.

In the current study, highly chemo-resistant human melanoma cells were grown in athymic mice and the animals treated either orally or intravenously with Anisina. Both dosage forms were equally effective.

Novogen Anti-Tropomyosin Program Director, Justine Stehn PhD, said, “We are pleasantly surprised by the degree of anti-tumor activity of this drug candidate on its own. We had always seen the anti-tropomyosin technology as being an adjunct therapy for the more commonly used anti-mitotic drugs. The rationale behind its development was to destroy that half of a cancer cell’s cytoskeleton that the anti-mitotic drugs didn’t target. We reasoned that destabilising the entire cytoskeleton would achieve a much higher level of anti-cancer effect than that coming from targeting either half alone. And, indeed, that is what we see. Anisina used in combination with anti-mitotic drug, vincristine, increases the anti-cancer potency of vincristine 20-fold.”

Stehn added, “Despite all the evidence showing that Anisina has the potential to be just as effective a stand-alone chemotherapy as the anti-mitotic drugs, we still intend to see Anisina as a companion drug for an anti-mitotic drug. The initial patients, however, will need to be treated with Anisina on its own, and this study now gives us the green light to proceed into a Phase 1 study in the first half of 2016.”

In preparation for both adult and paediatric clinical studies, the Company is conducting studies in a variety of both adult and paediatric solid and non-solid cancer types in order to determine the optimal drug combination. Data of the effectiveness of Anisina in combination with vincristine in animals bearing human neuroblastoma tumors is being presented to a conference in July 2015.

Graham Kelly, Novogen Group CEO, said, “Each step in the drug development process continues to build our confidence in the potential for this exciting first-in-class drug. The fact that we know its target and how it works; the fact that it is making the most commonly used drugs in chemotherapy work 20-times better, as well as looking like we can extend the effectiveness of the combination into tumor types traditionally unresponsive to anti-mitotic drugs; the fact that, in the case of melanoma anyway, its effectiveness is unaffected by mutational status; and the fact that it can be delivered conveniently by the oral route and in that form was well tolerated by animals with no observed side-effects: all these factors point to a highly versatile and promising new drug candidate with potentially broad application across the cancer spectrum.”

About Anisina

Anisina is a small molecule that specifically targets the tropomyosin isoform, Tpm3.1. Tropomyosins provide a rigid external scaffold to the central actin core of the microfilament component of a cell’s cytoskeleton. Without this rigidity, the microfilaments are inactive. There are over 40 different forms (isoforms) of tropomyosin of which Tpm3.1 is one. Tpm3.1 is present in all cells; normal cells are able to survive and function without Tpm3.1; cancer cells are highly dependent on the presence of Tpm3.1 for their survival and function. Exposure of cancer cells to Anisina leads to disassembly of their microfilaments, prevention of mitosis, and cell death. Anisina shows little or no effect on normal cells at therapeutic doses.

About Anti-mitotic drugs

Anti-mitotic drugs are drugs that block cell division (mitosis). This a shorthand term to describe a family of drugs that embraces the taxanes (paclitaxel, docetaxel, Abraxane) and vinca alkaloids (vincristine, vinblastine, Vineralbine) and which work by blocking the ability of cells to divide (mitosis). Their anti-cancer action is based on their inhibition of the protein, tubulin, which is the principal component of microtubules, which along with microfilaments, make up a cell’s cytoskeleton. The cytoskeleton (microtubules and microfilaments) is critical to most cell functions, but particularly cell signalling, receptor function, and mitosis.

The anti-mitotic drugs remain among the most widely prescribed anti-cancer drugs after 35 years of use and are standard of care for breast, prostate, lung, ovarian, colo-rectal, gastric and head and neck cancer, and many forms of leukaemia.

About Novogen

Novogen is a public, Australian-US drug development company whose shares trade on both The Australian Securities Exchange (NRT) and NASDAQ (NVGN). The Novogen group includes US-based, CanTx Inc, a joint venture company with Yale University. Novogen has two drug technology platforms yielding drug candidates that are first-in-class with potential application across a broad range of degenerative diseases. In the oncology field, the ultimate objective is to see both drug technologies used in combination as first-line therapy across most forms of cancer, with the objective of preventing tumor recurrence. This objective is based on a strategy of achieving comprehensive destruction of the full hierarchy of cells within a tumor with the super-benzopyran technology platform killing the tumor-initiating cells and the anti-tropomyosin technology, combined with vinca alkaloids, to deliver a potent chemical debunking effect on their daughter cells.

For more information, please visit

Corporate Contact

Dr. Graham Kelly

Executive Chairman & CEO

Novogen Group 

+61 (0) 2 9472 4100

Media Enquiries

Cristyn Humphreys

Chief Operating Officer

Novogen Group

+61 (0) 2 9472 4111

Forward Looking Statement

This press release contains “forward-looking statements” within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Exchange Act of 1934.  The Company has tried to identify such forward-looking statements by use of such words as “expects,” “appear,” “intends,” “hopes,” “anticipates,” “believes,” “could,” “should,” “would,”  “may,” “target,”  “evidences” and “estimates,” and other similar expressions, but these words are not the exclusive means of identifying such statements.  Such statements include, but are not limited to any statements relating to the Company’s drug development program, including, but not limited to the initiation, progress and outcomes of clinical trials of the Company’s drug development program, including, but not limited to, Anisina, and any other statements that are not historical facts.  Such statements involve risks and uncertainties, including, but not limited to, those risks and uncertainties relating to the difficulties or delays in financing, development, testing, regulatory approval, production and marketing of the Company’s drug components, including, but not limited to Anisina, the ability of the Company to procure additional future sources of financing, unexpected adverse side effects or inadequate therapeutic efficacy of the Company’s drug compounds, including, but not limited to, Anisina, that could slow or prevent products coming to market, the uncertainty of patent protection for the Company’s intellectual property or trade secrets, including, but not limited to, the intellectual property relating to Anisina, and other risks detailed from time to time in the filings the Company makes with Securities and Exchange Commission including its annual reports on Form 20-F and its reports on Form 6-K.  Such statements are based on management’s current expectations, but actual results may differ materially due to various factions including those risks and uncertainties mentioned or referred to in this press release.  Accordingly, you should not rely on those forward-looking statements as a prediction of actual future results.

Source: Novogen Ltd
Related Links:

Written by asiafreshnews

May 15, 2015 at 3:52 pm

Posted in Uncategorized

Mederi Therapeutic’s Stretta Becomes World’s Most Widely-Used Non-Surgical Treatment For Chronic GERD

leave a comment »

— 18,000 Stretta procedures performed since introduction, making Stretta the safest and most widely used endoluminal therapy for GERD
— Stretta expands reach with regulatory approvals added in large international markets

NORWALK, Conn., May 13, 2015 /PRNewswire/ — Mederi Therapeutics Inc. today announced two milestones in the worldwide growth of Stretta Therapy for GERD, which include the completion of the 18,000th Stretta procedure and new regulatory approvals in OUS markets of Mexico, India, South Africa, Australia, Argentina andSouth Korea.

Photo –

Dr. Mark Noar, Director of the Heartburn and Reflux Study Center, Towson, MD, one of the first adopters and top practitioners of Stretta said, “It’s rewarding to witness worldwide appreciation of how Stretta offers relief to patients with chronic GERD. More than 37 studies from five continents have clearly documented that Stretta is effective and safe, with the lowest reported complication rate of any non-drug option for GERD. These benefits offer value not just to patients, but also to health care providers and the entire health care system.” Dr. Noar is the author of the 10 year follow-up study of Stretta published in the journal Surgical Endoscopy in 2014.

Mederi also announced recent regulatory approvals with product launches underway in OUS markets includingMexico, India, South Africa, Australia, Argentina, and South Korea. During the launch in Mexico, Stretta cases were performed by Dr. David Aguirre, Director of Medical Arts Institute, at Doctors Hospital, and Hospital Angeles Valle Oriente, in Monterrey. Physician training programs were held at Hospital General Gea and The National Institute of Medical Science and Nutrition in Mexico City. Additionally, Stretta was the feature presentation at the recent Asociaciona Mexicana de Gastroenterologia – Semana Nacional de Gastroenterologia in Cancun, Mexico.

“Offering Stretta means we have a complete continuum of care for patients with chronic GERD,” Dr. Aguirre observed. “Patients now have an effective and safe option that doesn’t involve surgery and provides significant relief from symptoms. Besides the clinical benefit, Stretta delivers a significant cost savings for our health system due to the lower cost and complication rates coupled with elimination or significant reduction of lifelong medication use. Stretta is a game changer for us.”

Mederi also expects imminent approval in China, as Stretta has already cleared the first phase of Chinese regulatory requirements, with final clearance expected shortly.

Will Rutan, Chief Executive Officer of Mederi noted that these regulatory approvals add significantly to the current product reach. “Physician and patient interest for Stretta is extremely high in these countries,” Rutan said. “We are confident that the coming year will see continued growth of Stretta worldwide.”

Other countries and regions due for regulatory approval for Stretta in 2015 include, Brazil, Panama, Costa Rica,Russia, Egypt, Taiwan and the GCC.

Mederi Therapeutics manufactures Stretta and Secca – innovative medical devices that deliver non-ablative RF energy to treat digestive diseases. Both Stretta and Secca are proven safe and effective in multiple studies, with long-term data and growing insurance coverage.
For more information go to:

Contact: Julia Brannan
+1 (908) 464-2470

Source: Mederi Therapeutics Inc.

Written by asiafreshnews

May 15, 2015 at 3:46 pm

Posted in Uncategorized

SWI is Partner of the Global Forum on Modern Direct Democracy in Tunis

leave a comment »

BERN, Switzerland, May 13, 2015 /PRNewswire/ — Politicians, economists, media and researchers from around the world will gather in Tunis from May 14 to 17 to take part in the Global Forum on Modern Direct Democracy. As the forum’s media partner, SWI will report live from the event, and officially launch its microsite dedicated to direct democracy and its partner site,

To view the Multimedia News Release, please click:


The aim of the microsite – online in 10 languages since December 2014 – is to inform readers about political rights and democratic processes so they can form their own opinions in order to play a greater role in the decision-making process. Switzerland’s unique form of participative democracy is the focus of the site whereas offers a global view.

The theme of the Global Forum of Modern Democracy is “Decentralisation through participation in Tunisia and around the world”. Therefore it is an ideal showcase to launch Direct democracy is also an issue in the Arab-speaking world, and will be discussed in this manner for the first time at the event.

Politicians, representatives from national and international NGOs, universities and the media as well as members of the public will participate in the plenary discussions and workshops over the four days.

Follow the event with these hashtags: #citizenpower and #globfor15, and the Global Forum website will stream selected parts of the conference. Use the hashtags above to access the stream.


SWI – international service of the Swiss Broadcasting Corporation (SRG SSR)

SWI, Giacomettistrasse1, 3000 Bern 31, Switzerland,


Written by asiafreshnews

May 15, 2015 at 3:38 pm

Posted in Uncategorized

Neuberger Berman Appoints Former Central Banker Kent Chen To Lead Asia Private Equity Efforts

leave a comment »

NEW YORK and HONG KONG, May 13, 2015 /PRNewswire/ — Neuberger Berman, one of the world’s leading employee-owned investment managers, today announced the appointment of Kent Chen as Managing Director and leader of the firm’s private equity efforts in the Asia Pacific region.

In this newly-created role based in Hong Kong, Mr. Chen will advise local clients and lead the firm’s regional efforts investing in global private equity across a wide spectrum of strategies.

Mr. Chen joins Neuberger Berman from the Hong Kong Monetary Authority (HKMA) after 17 years of central banking career in various positions including Deputy Chief Representative of the HKMA’s New York Office and Advisor to the Executive Director for China at the International Monetary Fund in Washington D.C. From 2008, Mr. Chen helped to establish the HKMA’s private equity program, comprising of global buyout, Asia private equity and global energy investments.

Before joining the HKMA in 1998, Mr. Chen was Head of China Research at Daiwa Securities in Hong Kong covering the Chinese stocks market with a focus on infrastructure, energy and power equipment stocks.

Mr. Chen has been awarded the Chartered Financial Analyst designation and earned a Master of Public Administration from Columbia University, Master of Business Administration from University of Hull and Bachelor of Science in Economics from University of London.

Nick Hoar, Head of Asia Pacific, commented: “Kent brings to Neuberger Berman over two decades of investment and central banking experience. His skills will be invaluable as we strengthen our services, solutions and support to our clients in the Asia Pacific region who are increasing exposure to alternative asset classes, especially private equity.”

“With his extensive experience in global private equity, Kent is an excellent addition to the Neuberger Berman private equity business,” said Anthony Tutrone, Global Head of Alternatives. “We believe Kent’s appointment will enable us to deepen our presence in the Asia Pacific region and broaden the scope of our private equity capabilities globally.”

About Neuberger Berman

Neuberger Berman, founded in 1939, is a private, independent, employee-owned investment manager. The firm manages equities, fixed income, private equity and hedge fund portfolios for institutions and advisors worldwide. With offices in 18 countries, Neuberger Berman’s team is more than 2,100 professionals and the company was named by Pensions & Investments as a 2013 and 2014 Best Place to Work in Money Management. Tenured, stable and long-term in focus, the firm fosters an investment culture of fundamental research and independent thinking. It manages $251 billion in client assets as of March 31, 2015. For more information, please visit our website at

All information is as of March 31, 2015 unless otherwise indicated and is subject to change without notice. Firm data, including employee and assets under management figures, reflects collective data for the various affiliated investment advisers that are subsidiaries of Neuberger Berman Group LLC. Firm history dates back to the 1939 founding of Neuberger & Berman (the predecessor to Neuberger Berman LLC).

This material is being issued on a limited basis through various global subsidiaries and affiliates of Neuberger Berman Group LLC. Please visit for the specific entities and jurisdictional limitations and restrictions.

The “Neuberger Berman” name and logo are registered service marks of Neuberger Berman Group LLC. © 2015 Neuberger Berman Group LLC. All rights reserved.

Media Contact: Alex Samuelson, +1-212-476-5392,
Elina Choy, Asia, 852-3664-8835,

Logo –

Source: Neuberger Berman

Written by asiafreshnews

May 15, 2015 at 2:51 pm

Posted in Business & Finance

Countdown to Tissue World’s Sao Paulo Launch Next Week

leave a comment »

HONG KONG /PRNewswire/ — The Tissue World team is making the final touches to welcome the industry to our debut launch in Latin America!

Sao Paulo
Sao Paulo

The first edition of Tissue World Sao Paulo — the gateway to the tissue industry in Brazil and South America — will get underway at the Transamerica Expo Center in São Paulo from 20-22 May.

The tissue industry will gather to meet and mingle with key decision makers to get the latest on this vibrant and dynamic region.

Visitors will meet the whole supply chain, from pulp production in which Brazil is particularly strong, to tissue makers, suppliers and distributors.

We are proud to announce the many high profile companies that have registered to attend, including CMPC Celulosa, Perini, Eldorado Brasil Celulose, Kimberly-Clark Brasil, Valmet, Fibria Celulose, and many more!

To view the list of attendees so far go to:

In addition to the exhibition hall, visitors can keep pace with pressures from customers, regulators and advocacy groups by joining the discussion on the hot topics debated at the conference.

The final conference programme includes talks from the Bank of America Merrill Lynch’s Thiago Lofiego, Klabin’sFrancisco Razzolini, Huntsfield Brasil Consultancy’s Geraldo Ferreira, Euromonitor’s Leonardo Freitas, CMPC Tissue Puente Alto’s Armando Vera, WWF Chile’s Cecilia Alcoreza, and more.

Topics include: Global pulp market and supply/demand trends; Brazil’s tissue market opportunity; engaging in the world production chain; key trends and opportunities in the expanding Brazilian tissue and hygiene market.

For the final conference programme go to:

To register as a visitor is free of charge, go to:

For more information please visit

Tissue World is the leading global event series serving the tissue industry worldwide since 1993. An integrated and intertwined platform consisting of exhibitions, conferences and a magazine providing an unmatched offline and online meeting place to do business, exchange ideas and learn, all year round.

Contact Person: Ivan Ferrari
Phone Number: +65 6592 0888 ext 886

Photo –
Logo –

Source: Tissue World – UBM

Written by asiafreshnews

May 15, 2015 at 2:44 pm

Posted in Uncategorized